Search results for "ceftriaxone"

showing 10 items of 20 documents

Interventionelle ERCP bei Patienten mit Cholestase: Häufigkeit und Antibiotikaresistenz der biliären Keimbesiedlung

2001

Interventional ERCP in patients with cholestasis. Degree of biliary bacterial colonization and antibiotic resistance. Biliary obstruction together with bacterial colonization of the bile duct may lead to development of acute cholangitis. The aim of our prospective study was to investigate the presence and degree of biliary bacterial colonization by means of bile aspiration during ERCP in patients with biliary obstruction. Furthermore, we evaluated antibiotic therapy regimens, which would cover the bacterial species obtained by ERCP and subsequent culture in each patient. In addition, analysis of risk factors was performed that would predispose to the development of cholangitis.80 patients w…

medicine.medical_specialtyBile ductbusiness.industryGastroenterologymedicine.diseasedigestive systemGastroenterologydigestive system diseasesMetronidazolemedicine.anatomical_structureCholestasisLevofloxacinBacteremiaInternal medicinemedicineCeftriaxoneAnaerobic bacteriabusinessmedicine.drugAntibacterial agentZeitschrift für Gastroenterologie
researchProduct

Moxifloxacin versus Clindamycin/Ceftriaxone in the management of odontogenic maxillofacial infectious processes: a preliminary, intrahospital, contro…

2015

Background: The aim of this study was to compare the days of hospitalization length between patients treated with Moxifloxacin with that of patients treated with a Clindamycin/Ceftriaxone combination and additionally, to isolate and identify the oral pathogens involved in orofacial odontogenic infections. Material and Methods: A pilot-controlled-clinical-trial was carried out on hospitalized patients with cervicofacial odontogenic abscesses or cellulitis, who were randomly asigned to two study groups: 1) patients who received Moxifloxacin, and 2) patients receiving Clindamycin/Ceftriaxone combination. Infiltrate samples were collected through transdermic or transmucosal punction and later c…

medicine.medical_specialtyDebridementbusiness.industrymedicine.drug_classResearchmedicine.medical_treatmentAntibioticsClindamycinOdontologíamedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludClinical trialAntibiotic resistanceMoxifloxacinInternal medicineCellulitisUNESCO::CIENCIAS MÉDICASmedicineCeftriaxoneOral SurgerybusinessGeneral Dentistrymedicine.drug
researchProduct

Fatal multi-organ failure following anaphylactic shock induced by ceftriaxone

2014

In the latest years, based on the wide use of cephalosporins for antibiotic therapy, a large interest focused on the identification of causal relationship of adverse reactions after their prescription. We report a case of fatal anaphylactic shock following the administration of ceftriaxone in a woman who had tolerated the previous exposure to the drug. This case adds a contribution to the few cases reported in literature to further suggest the possibility of severe anaphylaxis after the administration of ceftriaxone even in patients without any previous reaction to this drug.

Adverse drug reaction; Anaphylaxis; Ceftriaxone; Cephalosporins; Multi-organ failure; Shock; Immunology and AllergySettore MED/43 - Medicina LegaleAnaphylaxiCeftriaxoneCephalosporinAdverse drug reactionImmunology and AllergyShockMulti-organ failureAnaphylaxisCephalosporins
researchProduct

Pyomyositis of the iliacus muscle complicated with septic sacroiliitis

2008

We report a rare case of pyomyositis of the iliacus muscle in a 29-year-old woman. After 2 weeks of adequate treatment, secondary septic sacroiliitis occurred, a complication that had not been described previously. Pyomyositis of the iliacus muscle must be considered in the differential diagnosis of acute pain in the hip region.

AdultStaphylococcus aureusmedicine.medical_specialtyPyomyositisSeptic SacroiliitisPainIliumPyomyositismedicineHumansOsteitisMyositisSacroiliac jointHipbusiness.industryCeftriaxoneSacroiliitisSacroiliac JointGeneral MedicineStaphylococcal Infectionsmedicine.diseaseMagnetic Resonance ImagingSurgerymedicine.anatomical_structureIliacus muscleFemaleDifferential diagnosisComplicationbusinessCloxacillinQJM
researchProduct

Renal and nonrenal clearances of ceftriaxone at the steady-state and its relation to plasma protein binding

1995

Abstract The effect of the saturable plasma protein binding of ceftriaxone on the elimination of this drug was studied under steady-state conditions in the rat. A concentration-dependent increase in the total, renal and nonrenal clearances of total drug (bound + unbound) was observed, and it was related to the increase in the ex vivo unbound fraction of ceftriaxone as the plasma concentration increased. The nonrenal clearance of the unbound ceftriaxone showed a statistically significant decrease as the plasma concentration of the unbound drug at the steady state increased, which indicates that the nonrenal elimination of the drug (mainly by biliary excretion) is a saturable process. Renal c…

Kidneymedicine.medical_specialtyChemistryPharmaceutical ScienceRenal functionmedicine.anatomical_structureEndocrinologyPharmacokineticsRenal physiologyInternal medicineBlood plasmamedicineCeftriaxoneSteady state (chemistry)medicine.drugAntibacterial agentEuropean Journal of Pharmaceutical Sciences
researchProduct

Optimal treatment of leptospirosis: queries and projections.

2006

Although the global burden of leptospirosis remains enormous and new aspects of the disease are constantly recognised, little progress has been achieved in the field of leptospirosis therapeutics and queries regarding the utility of antibiotics in the late severe form of the disease remain. From the currently existing data, conclusions on the efficacy of antibiotic administration in severe or late disease cannot easily be drawn, since clinical trials have different selection criteria and may focus on Leptospira serovars with different virulence. However, as a rule the benefit of the doubt should apply. Moreover, new options, such as ceftriaxone, have a superior safety profile to penicillin.…

Microbiology (medical)medicine.medical_specialtymedicine.drug_classAntibioticsDiseaseLeptospirosiMiceLeptospiramedicineAnimalsHumansPharmacology (medical)LeptospirosisIntensive care medicineAntibacterial agentLeptospirabiologybusiness.industryOptimal treatmentCeftriaxoneGeneral Medicinemedicine.diseasebiology.organism_classificationPenicillinLeptospirosisAnti-Bacterial AgentsClinical trialTreatmentSafety profileInfectious DiseasesDoxycyclineImmunologybusinessInternational journal of antimicrobial agents
researchProduct

DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?

2014

Background. Morbidity and mortality for critically ill patients with infections remains a global healthcare problem. We aimed to determine whether α-lactam antibiotic dosing in critically ill patients achieves concentrations associated with maximal activity and whether antibiotic concentrations affect patient outcome.Methods. This was a prospective, multinational pharmacokinetic point-prevalence study including 8 α-lactam antibiotics. Two blood samples were taken from each patient during a single dosing interval. The primary pharmacokinetic/pharmacodynamic targets were free antibiotic concentrations above the minimum inhibitory concentration (MIC) of the pathogen at both 50% (50% f TMIC) an…

MaleInternational CooperationAntibioticsadverse eventintensive care unitlaw.invention0302 clinical medicinemeropenemModels[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesadverse events; continuous infusion; extended infusion; pharmacodynamics; pharmacokinetics; Aged; Anti-Bacterial Agents; Bacterial Infections; Blood Chemical Analysis; Female; Humans; Intensive Care Units; International Cooperation; Male; Microbial Sensitivity Tests; Middle Aged; Models Statistical; Prospective Studies; Treatment Outcome; beta-Lactams; Critical Illnessantibiotic therapyProspective Studiesamoxicillin plus clavulanic acidComputingMilieux_MISCELLANEOUSbeta lactam antibioticAPACHE0303 health sciencescritical illneadultclinical trial3. Good healthcontinuous infusion; extended infusion; adverse events; pharmacokinetics; pharmacodynamics.antiinfective agent[SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitologypriority journaldisease severitybeta-Lactamstatistical model Agedprospective studyHumanMicrobiology (medical)medicine.medical_specialtydrug exposureCritical IllnessImmunologybloodstream infectionMicrobial Sensitivity Testspiperacillin plus tazobactambeta-LactamsMicrobiologybeta lactam abdominal infection03 medical and health sciencescritically ill patientIntensive careAnti-Bacterial AgentcefepimepharmacodynamicsHumansDosingAdverse effectAgedModels Statistical030306 microbiologyOdds ratiomajor clinical studymortalityantibiotic sensitivityceftriaxoneProspective Studiemulticenter studypharmacodynamics.ampicillinBlood Chemical AnalysisCeftazidimeSettore MED/41 - AnestesiologiaInterquartile rangelaw030212 general & internal medicinepharmacokineticlung infectionMicrobial Sensitivity TestarticleBacterial InfectionsMiddle AgedStatisticalcontinuous infusionIntensive care unitAnti-Bacterial Agentsextended infusionIntensive Care UnitsInfectious DiseasesTreatment Outcomeadverse events; continuous infusion; extended infusion; pharmacodynamics; pharmacokinetics; Aged; Anti-Bacterial Agents; Bacterial Infections; Blood Chemical Analysis; Female; Humans; Intensive Care Units; International Cooperation; Male; Microbial Sensitivity Tests; Middle Aged; Models Statistical; Prospective Studies; Treatment Outcome; beta-Lactams; Critical Illness; Microbiology (medical); Infectious Diseasescefazolin[SDV.IMM]Life Sciences [q-bio]/Immunologyblood samplingFemalepharmacokineticsmedicine.drugmedicine.drug_classprevalencedoripenemminimum inhibitory concentrationBacterial InfectionInternal medicinemedicinecontrolled studyblood analysibusiness.industryBlood Chemical Analysiadverse eventsSurgerypharmacodynamicdrug blood levelbusiness
researchProduct

Analysis of ceftriaxone and ceftazidime distribution in cerebrospinal fluid of and cerebral extracellular space in awake rats by in vivo microdialysis

1995

In vivo microdialysis was used to estimate the extracellular concentrations of ceftazidime and ceftriaxone, two expanded-spectrum cephalosporins commonly used in the treatment of bacterial meningitis, in two brain regions (the right corpus striatum and the left lateral ventricle) of awake, freely moving rats. Antibiotics were administered by constant intravenous infusion at 18 mg/h until steady-state levels were reached. Ceftriaxone levels measured at the steady state in the extracellular space of the corpus striatum (0.80 ± 0.17 J.tg/ml) were statistically equivalent to those obtained in the cerebrospinal fluid of the lateral ventricle (0.71 ± 0.15 J.tg/ml). The ratios of these levels in t…

MaleMicrodialysismedicine.medical_specialtyMicrodialysisCeftazidimeCeftazidimeCerebral VentriclesCerebrospinal fluidIn vivoInternal medicineExtracellularAnimalsMedicinePharmacology (medical)Rats WistarInfusions IntravenousAntibacterial agentPharmacologybusiness.industryCeftriaxoneBrainHalf-lifeCorpus StriatumCephalosporinsRatsInfectious DiseasesEndocrinologyAnesthesiaCeftriaxoneExtracellular SpacebusinessResearch ArticleHalf-Lifemedicine.drug
researchProduct

Neisseria gonorrhoeae antimicrobial resistance in Spain: a prospective multicentre study.

2021

Abstract Objectives Gonococcal infection is one of the most reported sexually transmitted infections and antimicrobial resistance in Neisseria gonorrhoeae (NG) is challenging for the treatment of this infection. This observational study aimed to describe antimicrobial resistance of NG and epidemiological data from patients with gonococcal infection in eight regions of Spain, for updating the local therapeutic guidelines. Methods MICs of penicillin, cefixime, ceftriaxone, azithromycin, ciprofloxacin, fosfomycin and gentamicin were determined by Etest for all NG isolates recovered from 1 April 2018 to 30 September 2019 from 10 hospitals in Spain. Resistance determinants were identified using …

0301 basic medicineMicrobiology (medical)Malemedicine.medical_specialty030106 microbiologyMicrobial Sensitivity TestsFosfomycinAzithromycinAzithromycinmedicine.disease_cause03 medical and health sciencesGonorrheaSexual and Gender Minorities0302 clinical medicineAntibiotic resistanceCiprofloxacinInternal medicineDrug Resistance BacterialmedicineHumansPharmacology (medical)030212 general & internal medicineProspective StudiesHomosexuality MaleEtestPharmacologybusiness.industryCeftriaxoneNeisseria gonorrhoeaeAnti-Bacterial AgentsPenicillinCiprofloxacinInfectious DiseasesSpainNeisseria gonorrhoeaebusinessCefiximemedicine.drugThe Journal of antimicrobial chemotherapy
researchProduct

Neuroprotective effect of ceftriaxone on the penumbra in a rat venous ischemia model.

2012

Glutamate transporter-1 (GLT-1) maintains low concentrations of extracellular glutamate by removing glutamate from the extracellular space. It is controversial, however, whether upregulation of GLT-1 is neuroprotective under all ischemic/hypoxic conditions. Recently, a neuroprotective effect of preconditioning with a β-lactam antibiotic ceftriaxone (CTX) that increases expression of GLT-1 has been reported in animal models of focal ischemia. On the other hand, it is said that CTX does not play a neuroprotective role in an in vitro study. Thus, we examined the effect of CTX on ischemic injury in a rat model of two-vein occlusion (2VO). This model mimics venous ischemia during, e.g. tumor sur…

MaleIschemiaAMPA receptorPharmacologyNeuroprotectionReceptors N-Methyl-D-AspartateBrain IschemiaPotassium Chloridechemistry.chemical_compoundMedicineAnimalsDrug InteractionsReceptors AMPAKainic Acidbusiness.industryGABAA receptorGeneral NeuroscienceCeftriaxoneCortical Spreading DepressionGlutamate receptorCerebral Infarctionmedicine.diseaseReceptors GABA-AAnti-Bacterial AgentsRatsNeuroprotective AgentsMuscimolchemistryExcitatory Amino Acid Transporter 2Cortical spreading depressionAnesthesiaNMDA receptorbusinessNeuroscience
researchProduct